Lv11
40 积分 2024-01-07 加入
Perioperative immunotherapy plus chemotherapy versus chemotherapy alone for patients with resectable pulmonary lymphoepithelioma-like carcinoma
5小时前
已完结
Body composition and lung cancer-associated cachexia in TRACERx
2个月前
已完结
[Impact of neoadjuvant immunotherapy on pulmonary function and perioperative outcomes in patients with resectable non-small cell lung cancer]
3个月前
已完结
Current advances in nanozyme-based nanodynamic therapies for cancer
3个月前
已完结
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
3个月前
已完结
Radiomics features as predictive and prognostic biomarkers in NSCLC
5个月前
已完结
Clinical stage IA non-small cell lung cancer with occult pathologic N1 and N2 disease after segmentectomy: does a completion lobectomy justify?
5个月前
已完结
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study
5个月前
已完结
SMARCA4: Current status and future perspectives in non-small-cell lung cancer
6个月前
已完结
Immunotherapy-based combinations in metastatic NSCLC
6个月前
已完结
皖公网安备34019202002308
